Literature DB >> 15695318

No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome.

D Söderlund1, P Canto, S Carranza-Lira, J P Méndez.   

Abstract

BACKGROUND: Etiology and inheritance pattern in polycystic ovary syndrome (PCOS) remain uncertain. Granulosa cells from follicles of women with PCOS have little, if any, aromatase (encoded by the CYP19 gene) activity; follicles contain low levels of estradiol, P450arom mRNA and aromatase stimulating bioactivity. Mice with targeted disruption of the CYP19 gene present cystic follicles. It has been proposed that chronic exposure to high levels of LH, because of aromatase deficiency, determines the development of ovarian cysts. Herein, we investigated if mutations in the CYP19 gene and/or its ovary promoter are causal in patients with PCOS.
METHODS: Twenty-five patients with PCOS and 50 control women were studied. PCR analysis of genomic DNA and complete sequence of all exons of the aromatase gene and its ovary promoter were performed.
RESULTS: No heterozygous or homozygous mutant alleles were present in any of the patients studied.
CONCLUSIONS: In the population studied, mutations of the P450arom gene or its promoter are not the cause of PCOS. However, these findings do not preclude the possible importance of an aromatase disorder in PCOS etiology. Variations in aromatase complex function could play a role in PCOS etiology, but the determinants of such variations might be located in other genes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15695318     DOI: 10.1093/humrep/deh690

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

1.  Histone demethylase KDM4A and KDM4B expression in granulosa cells from women undergoing in vitro fertilization.

Authors:  Adam J Krieg; Sarah R Mullinax; Frances Grimstad; Kaitlin Marquis; Elizabeth Constance; Yan Hong; Sacha A Krieg; Katherine F Roby
Journal:  J Assist Reprod Genet       Date:  2018-03-14       Impact factor: 3.412

2.  Genetic association study from North India to analyze association of CYP19A1 and CYP17A1 with polycystic ovary syndrome.

Authors:  Ratneev Kaur; Tajinder Kaur; Anupam Kaur
Journal:  J Assist Reprod Genet       Date:  2018-03-22       Impact factor: 3.412

3.  Effects of BMAL1-SIRT1-positive cycle on estrogen synthesis in human ovarian granulosa cells: an implicative role of BMAL1 in PCOS.

Authors:  Jiaou Zhang; Jiansheng Liu; Kai Zhu; Yan Hong; Yun Sun; Xiaoming Zhao; Yanzhi Du; Zi-Jiang Chen
Journal:  Endocrine       Date:  2016-04-27       Impact factor: 3.633

4.  The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma.

Authors:  Ugur Unluturk; Ayla Harmanci; Cetin Kocaefe; Bulent O Yildiz
Journal:  PPAR Res       Date:  2007       Impact factor: 4.964

5.  The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome.

Authors:  Jie Chen; Shanmei Shen; Yong Tan; Dong Xia; Yanjie Xia; Yunxia Cao; Wenjun Wang; Xiaoke Wu; Hongwei Wang; Long Yi; Qian Gao; Yong Wang
Journal:  J Ovarian Res       Date:  2015-03-22       Impact factor: 4.234

Review 6.  Relationship between Advanced Glycation End Products and Steroidogenesis in PCOS.

Authors:  Deepika Garg; Zaher Merhi
Journal:  Reprod Biol Endocrinol       Date:  2016-10-21       Impact factor: 5.211

7.  Association between CYP19 gene SNP rs2414096 polymorphism and polycystic ovary syndrome in Chinese women.

Authors:  Jia-Li Jin; Jing Sun; Hui-Juan Ge; Yun-Xia Cao; Xiao-Ke Wu; Feng-Jing Liang; Hai-Xiang Sun; Lu Ke; Long Yi; Zhi-Wei Wu; Yong Wang
Journal:  BMC Med Genet       Date:  2009-12-16       Impact factor: 2.103

8.  Impact of rs2414096 polymorphism of CYP19 gene on susceptibility of polycystic ovary syndrome and hyperandrogenism in Kashmiri women.

Authors:  Sairish Ashraf; Shayaq Ul Abeer Rasool; Mudasar Nabi; Mohd Ashraf Ganie; Shariq R Masoodi; Shajrul Amin
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.